USFDA grants Breakthrough Designation to Datar Cancer Genetics for blood test detecting prostate cancer, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The approved blood test can detect early-stage prostate cancers with more than 99 percent accuracy without any false positives. It has been validated in large clinical studies involving healthy males and prostate cancer patients., The approved blood test can detect early-stage prostate cancers with more than 99 percent accuracy without any false positives. It has been validated in large clinical studies involving healthy males and prostate cancer patients., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *